Overview Presentation ManukaMed LLC Overview Presentation

ManukaMed /Watson and Sons, New Zealand Founded by Denis Watson in 2005 “The world leader in honey science” Only end to end provider of medical products using Manuka honey Complete control of the entire beginning (manuka flower) to end (your practice) process Quality Bioactive Testing & Assurance (QBTA) assures potency and consistency Over 30,000+ hives, 200,000 acres strategically located in New Zealand Patent pending process on purification, qualification and manufacture - QBTA Entering the US market as ManukaMed USA in Q4 2014

Confidential and Proprietary to Watson & Son Limited Manuka Forest Mono floral forests are essential to ensure pure harvest of Manuka honey Confidential and Proprietary to Watson & Son Limited

Manuka Flower

Aotearoa-New Zealand Hive sites in the North Island Confidential and Proprietary to Watson & Son Limited

MANUKAMED vs. other medical grade honey’s Other Medical Honeys Comments Consistent potency & consistency in all medical grade all dressings +++++ 100% Leptospermum Scoparium ++ NOT 100% Leptospermum Scoparium (blends of 80% or less) Supply chain process unique to ManukaMed In vitro activity MRSA, E coli, Pseudomonas, Acinetobacter, Bacteroides +++++ +++ Poster SAWC spring 2014 by Dr. Shaun Carpenter Anti- Inflammatory effects ? No studies Patent pending registered 2Q 2014 Osmotic Pump Debridement effects ++++++ Peter Molan reference articles –SAF exchange Exudate Management (maceration control) + (need 2nd foam/absorptive dressings) Patented and exclusive super absorbent fiber (SAF) Odor control ++++ ManukaMed honey at low % concentrations

Comparison of ManukaMed vs other medical grade honeys Comparison of ManukaMed vs other medical grade honeys * Variable Antimicrobial Activity of 3 Different Medical Manuka Honeys – S. Carpenter, MD, T. Shaffett, APRN, CWS, Lakeview Regional Medical Center, Covington LA 29% > 25% > Bottom line: MANUKApli showed 29% greater activity vs. MRSA and 25% greater activity vs. E coli vs. closest competitor – Medihoney (Derma Sciences)

MANUKAMED Honey Application & Effects Honey held in interstitial spaces Honey dispersion & exudate absorption Bioactive properties released Autolytic debridement and odor reduction Promotes accelerated natural wound healing

The MANUKAMED Honey difference Not all Manuka honey’s are created equal Patented cross-linked fiber mesh

Comparative Study ManukaMed vs Derma Absorption Capacity of Dressings

MANUKAMED Family of Products

Product Description Product Code Packaging Dimension HCPCS MANUKAtex Honey impregnated sterile acetate gauze MM0010 10/box - 20 box / Case 4” x 5” 10 x 12.5cm A6403 MANUKAhd lite Honey impregnated super absorbent gelling fiber MM0030 2” x 2” 5 x 5cm A6196 MM0031 A6197 MANUKAhd Honey impregnated super absorbent gelling fiber* MM0013 MM0017 MANUKApli 100% Leptospermum MM0049 5/box - 10 box/case 2 x 0.5 oz tubes 2 x 15g tube NA MANUKAderm Skin Barrier Protectant Cream with 30% Manuka Honey MM0053 6/box - 6 box/case 1.75 oz tube 50g tube

Clinical Results – Before & After

Venous Leg Ulcer Before After 7 Days

Arterial Leg Ulcer Before – Had for 2 years After – Healed 7 weeks

Diabetic Ulcer Before After 6 weeks

Pressure Ulcer Before After 7 days 18

Necrotizing Fasciitis Before After 3 days with graft After 7 days with graft 19

Open Heart Surgery Before 8 Days After 20 20

In Summary ManukaMed USA… Has the highest quality 100% leptospermum scoparium (medical grade) honey in the world Has established a direct go to market sales and marketing operation in the USA to serve all points of distribution and sales ManukaMed products have demonstrated bioactive benefits in addition to autolytic debridement and odor control Is now set logistically up to provide a direct way to purchase our entire product line through Mercy Surgical, Pittsburgh PA/IMCO & Metro Park Fulfillment Center, Kansas City MO For more information please e-mail barbara.folb@manukamed.com or call 203-300-6031

Watson & Son™ Manuka Honey The higher activity levels are harder to source and this is reflected in the price. Anything that is less than 10+ is likely to have a significant Kanuka presence. You would need to consume more of 10+ to achieve the same efficacy as less of the higher grades.

Press Release-June 2015 MANUKAMED CONTINUES TO LEAD THE WAY WITH HONEY WOUND DRESSING REIMBURSEMENT! On June 17, 2015 CMS decided to assign a miscellaneous surgical supply HCPCS code to certain honey dressings that do not meet fixed fee schedule requirements. This means that if you are a prescribing clinician using certain Manuka honey products that have been assigned the new HCPCS code A4649, increased documentation and narrative requirements will be necessary before reimbursement is considered. ManukaMed is still the ONLY Company able to provide Manuka honey advanced wound care dressings with fixed fee HCPCS codes as follows: MANUKAhd 2” x 2” (A6196) MANUKAhd 4”x 5” (A6197) MANUKAhd lite 2” x 2” (A6196) MANUKAhd Lite 4” x 5” (A6197) MANUKAhd Lite rope 0.5” x 18.7” (A6199) MANUKAtex 4” x 5” (A6403) Please note that all the codes listed above are fixed fee HCPCS codes meaning that the process you have already been using for reimbursement submission has not and will not change. .